Philipp Martin

Philipp Martin advises prominent financial sponsors on investments in private and public companies, including acquisitions, disposals, joint ventures, minority and majority investments, structured or hybrid transactions, co-investments, and management equity programs. He has advised on matters across a range of sectors, including business services, technology, industrial, financial services, and health care. In addition, his practice includes cross-border M&A and other strategic legal advice for corporate clients.

Philipp also gained significant in-house experience during a six-month secondment to the investment legal team of Partners Group in Zug, Switzerland.

Prior to joining Jones Day in 2025, Philipp represented Riverside on the investment into GFOS, a software provider in the areas of workforce management, access control, and manufacturing execution systems; Nimbus Private Equity on the sale of Extrusion Technology Group to Gamut Capital's portfolio company Davis-Standard; Brookfield Asset Management on the intended acquisition of a testing and inspection business in the oil and gas infrastructure space; a consortium comprising of Life Sciences Partners (now EQT Life Sciences), HealthCap, and Pureos Bioventures on the carve-out of Ariceum Therapeutics from pharma company Ipsen; Charterhouse Capital Partners on the acquisition of telecommunications company Telio Management from DBAG; Advent International on the sale of allnex group to PTT Global Chemical; APAX Partners on various matters, including the acquisition of WSGN from Ascential; and Centerbridge on various matters, including Auxmoney and the intended acquisition of a stake in Norddeutsche Landesbank.